Literature DB >> 11896041

Regional measurement of canine skeletal muscle blood flow by positron emission tomography with H2(15)O.

Alan J Fischman1, Hongbing Hsu, Edward A Carter, Yong M Yu, Ronald G Tompkins, J Luis Guerrero, Vernon R Young, Nathaniel M Alpert.   

Abstract

Positron emission tomography (PET) with H2(15)O was used as an in vivo, relatively noninvasive, quantitative method for measuring regional blood flow to hindlimb skeletal muscle of anesthetized dogs. A hydrooccluder positioned on the femoral artery was used to reduce flow, and high-flow states were produced by local infusion of adenosine. Three to four measurements were made in each animal. Approximately 40 mCi of H2(15)O were injected intravenously, and serial images and arterial blood samples were acquired over 2.5 min. Data analysis was performed by fitting tissue and arterial blood time-activity curves to a modified, single-compartment Kety model. The model equation was also solved on a pixel-by-pixel basis to yield maps of regional skeletal muscle blood flow. After each PET determination, flow was measured with radioactive microspheres. Results of the PET measurements demonstrated that basal flow to hindlimb skeletal muscle was 3.83 +/- 0.36 ml x min(-1) x 100 g(-1) (mean +/- SE). This value was in excellent agreement with the microsphere data, 3.73 +/- 0.32 ml x min(-1) x 100 g(-1) (P = 0.69, not significant). Adenosine infusion resulted in flows as high as 30 ml x min(-1) x 100 g(-1), and the PET and microsphere data were highly correlated over the entire range of flows (r2 = 0.98, P < 0.0001). We conclude that muscle blood flow can be accurately measured in vivo by PET with H2(15)O and that this approach offers promise for application in human studies of muscle metabolism under varying pathophysiological states.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11896041     DOI: 10.1152/japplphysiol.00445.2001

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  7 in total

1.  Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia.

Authors:  Michael P Murphy; Jeffrey H Lawson; Brian M Rapp; Michael C Dalsing; Janet Klein; Michael G Wilson; Gary D Hutchins; Keith L March
Journal:  J Vasc Surg       Date:  2011-04-22       Impact factor: 4.268

2.  Muscle fractal vascular branching pattern and microvascular perfusion heterogeneity in endurance-trained and untrained men.

Authors:  Kari K Kalliokoski; Tom A Kuusela; Marko S Laaksonen; Juhani Knuuti; Pirjo Nuutila
Journal:  J Physiol       Date:  2003-01-15       Impact factor: 5.182

3.  The effect of acute exercise with increasing workloads on inactive muscle blood flow and its heterogeneity in humans.

Authors:  Ilkka Heinonen; Dirk J Duncker; Juhani Knuuti; Kari K Kalliokoski
Journal:  Eur J Appl Physiol       Date:  2012-10       Impact factor: 3.078

4.  State-of-the-Art Methods for Evaluation of Angiogenesis and Tissue Vascularization: A Scientific Statement From the American Heart Association.

Authors:  Michael Simons; Kari Alitalo; Brian H Annex; Hellmut G Augustin; Craig Beam; Bradford C Berk; Tatiana Byzova; Peter Carmeliet; William Chilian; John P Cooke; George E Davis; Anne Eichmann; M Luisa Iruela-Arispe; Eli Keshet; Albert J Sinusas; Christiana Ruhrberg; Y Joseph Woo; Stefanie Dimmeler
Journal:  Circ Res       Date:  2015-04-30       Impact factor: 17.367

Review 5.  Clinical Applications for Radiotracer Imaging of Lower Extremity Peripheral Arterial Disease and Critical Limb Ischemia.

Authors:  Ting-Heng Chou; Mitchel R Stacy
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

6.  Glucose metabolism during the early "flow phase" after burn injury.

Authors:  Hongzhi Xu; Yong-Ming Yu; Harry Ma; Edward A Carter; Shawn Fagan; Ronald G Tompkins; Alan J Fischman
Journal:  J Surg Res       Date:  2012-03-10       Impact factor: 2.192

Review 7.  Novel Applications of Radionuclide Imaging in Peripheral Vascular Disease.

Authors:  Mitchel R Stacy; Albert J Sinusas
Journal:  Cardiol Clin       Date:  2015-10-17       Impact factor: 2.213

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.